Douglas J Phillips

Years Active: 2018-2018
Publications (10 Years): 1

Cell Medica (Switzerland)

Cambridge Antibody Technology / University of Reading (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cell Medica (Switzerland)

Switzerland

Scientist II

Delenex (Switzerland)

Switzerland

Scientist II

Molecular Partners AG

Switzerland

Expert Scientist

Education History

Cambridge Antibody Technology / University of Reading

United Kingdom

PHD

University of Glasgow

United Kingdom

BSC

Publications

Michael T Stumpp, Talitha R Bakker, Douglas J Phillips, Andreas Cornelius, Christof Zitt, Thomas Göttler, Gabriel Sigrist, Ulrike Fiedler, Savira Ekawardhani, Ignacio Dolado, Johan Abram Saliba, Gaby Tresch, Karl Proba, Michael T Stumpp
Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidate. mAbs 9 (8) (2018)

Douglas J Phillips.css-eqlu8i{font-size:small;padding-left:4px;}